Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (MK-6024-016)
Public ClinicalTrials.gov record NCT06482112. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2a Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Different Dosing Regimens of Efinopegdutide (MK-6024) in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease
Study identification
- NCT ID
- NCT06482112
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Merck Sharp & Dohme LLC
- Industry
- Enrollment
- 124 participants
Conditions and interventions
Conditions
Interventions
- Efinopegdutide Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 28, 2024
- Primary completion
- Jun 26, 2025
- Completion
- Jun 26, 2025
- Last update posted
- May 31, 2026
2024 – 2025
United States locations
- U.S. sites
- 36
- U.S. states
- 10
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The Institute for Liver Health II dba Arizona Clinical Trial-The Institute for Liver Health ( Site 0 | Chandler | Arizona | 85224 | — |
| The Institute for Liver Health II dba Arizona Liver Health - Peoria ( Site 0224) | Peoria | Arizona | 85381 | — |
| Arizona Liver Health ( Site 0211) | Tucson | Arizona | 85712 | — |
| Del Sol Research Management, LLC ( Site 0209) | Tucson | Arizona | 85715 | — |
| Om Research LLC ( Site 0207) | Camarillo | California | 93012 | — |
| Gastroenterology and Liver Institute ( Site 0263) | Escondido | California | 92025 | — |
| Velocity Clinical Research, Gardena ( Site 0235) | Gardena | California | 90247 | — |
| Velocity Clinical Research, Huntington Park ( Site 0210) | Huntington Park | California | 90255 | — |
| California Liver Research Institute ( Site 0216) | Pasadena | California | 91105 | — |
| Acclaim Clinical Research ( Site 0241) | San Diego | California | 92120 | — |
| Velocity Clinical Research, Santa Ana ( Site 0250) | Santa Ana | California | 92704 | — |
| Velocity Clinical Research, Panorama City ( Site 0228) | Van Nuys | California | 91405 | — |
| Excel Medical Clinical Trials ( Site 0268) | Boca Raton | Florida | 33434 | — |
| AGA Clinical Trials ( Site 0274) | Hialeah | Florida | 33012 | — |
| Neoclinical Research ( Site 0275) | Hialeah | Florida | 33016 | — |
| Homestead Associates in Research, Inc. ( Site 0243) | Homestead | Florida | 33033 | — |
| Floridian Clinical Research, LLC ( Site 0208) | Miami Lakes | Florida | 33016 | — |
| Southeast Clinical Research Center ( Site 0223) | Dalton | Georgia | 30720 | — |
| Velocity Clinical Research Rockville ( Site 0245) | Rockville | Maryland | 20854 | — |
| The Machuca Foundation ( Site 0218) | Las Vegas | Nevada | 89101 | — |
| Excel Clinical Research, LLC ( Site 0200) | Las Vegas | Nevada | 89109 | — |
| Basil Clinical ( Site 0246) | Inwood | New York | 11096 | — |
| Lucas Research, Inc ( Site 0204) | Morehead City | North Carolina | 28557 | — |
| Texas Clinical Research Institute ( Site 0230) | Arlington | Texas | 76012 | — |
| Pinnacle Clinical Research ( Site 0203) | Austin | Texas | 78757 | — |
| Velocity Clinical Research, Austin ( Site 0201) | Austin | Texas | 78759 | — |
| Pinnacle Clinical Research-Corpus Christi ( Site 0267) | Corpus Christi | Texas | 78404 | — |
| Zenos Clinical Research ( Site 0240) | Dallas | Texas | 75230 | — |
| South Texas Research Institute ( Site 0226) | Edinburg | Texas | 78539 | — |
| Houston Research Institute ( Site 0221) | Houston | Texas | 77079 | — |
| American Research Corporation ( Site 0234) | San Antonio | Texas | 78215 | — |
| Clinical Trials of Texas, LLC-Clinical Research ( Site 0252) | San Antonio | Texas | 78229 | — |
| Pinnacle Clinical Research-Clinical Research Coordination ( Site 0229) | San Antonio | Texas | 78229 | — |
| Impact Research Institute ( Site 0227) | Waco | Texas | 76710 | — |
| Olympus Family Medicine/CCT Research ( Site 0266) | Holladay | Utah | 84117 | — |
| South Ogden Family Medicine/ CCT Research ( Site 0255) | South Ogden | Utah | 84405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06482112, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 31, 2026 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06482112 live on ClinicalTrials.gov.